Abaloparatide Increases Lumbar Spine and Hip BMD in Japanese Patients With Osteoporosis: The Phase 3 ACTIVE-J Study

CONTEXT: Abaloparatide reduced fracture risk in postmenopausal women with osteoporosis in the Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE). Its effect in Japanese patients remains unexamined. OBJECTIVE: This work aimed to determine the efficacy and safety of abaloparatide in increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Toshio, Sone, Teruki, Soen, Satoshi, Tanaka, Sakae, Yamashita, Akiko, Inoue, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516124/
https://www.ncbi.nlm.nih.gov/pubmed/35977548
http://dx.doi.org/10.1210/clinem/dgac486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516124/
https://www.ncbi.nlm.nih.gov/pubmed/35977548
http://dx.doi.org/10.1210/clinem/dgac486

Ejemplares similares